Evidence map›Paper›PMID 41631208›Full record

ArticleMaterials today. Bio2026

Bioprinting and assembly of organ building blocks for tissue engineering applications.

Jae-Hun Kim, Guolong Jin, Jaehyeon Kim, Chanhyeock Kim, Chanhan Kang, Sunwoo Lee, Jin-Hyung Shim, Won-Soo Yun, Songwan Jin

Abstract read
In one paragraph

Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jae-Hun KimDepartment of Mechanical Engineering, Tech University of Korea, Siheung-si, Gyeonggi-do, Republic of Korea.
Guolong JinDepartment of Mechanical Engineering, Tech University of Korea, Siheung-si, Gyeonggi-do, Republic of Korea.
Jaehyeon KimDepartment of Mechanical Engineering, Tech University of Korea, Siheung-si, Gyeonggi-do, Republic of Korea.
Chanhyeock KimDepartment of Mechanical Engineering, Tech University of Korea, Siheung-si, Gyeonggi-do, Republic of Korea.
Chanhan KangDepartment of Mechanical Engineering, Tech University of Korea, Siheung-si, Gyeonggi-do, Republic of Korea.
Sunwoo LeeT&R Biofab Co., Ltd., Siheung-si, Gyeonggi-do, Republic of Korea.
Jin-Hyung ShimDepartment of Mechanical Engineering, Tech University of Korea, Siheung-si, Gyeonggi-do, Republic of Korea.
Won-Soo YunDepartment of Mechanical Engineering, Tech University of Korea, Siheung-si, Gyeonggi-do, Republic of Korea.
Songwan JinDepartment of Mechanical Engineering, Tech University of Korea, Siheung-si, Gyeonggi-do, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Damage or functional failure of vital organs remains a major clinical challenge, while the availability of donor organs for transplantation is severely limited. As a result, tissue engineering has emerged as a promising strategy for organ replacement; however, conventional top-down tissue engineering, which employs scaffolds to provide three-dimensional growth environments, cannot ensure precise cell positioning, restricting its applicability to complex and heterogeneous tissues. In contrast, bottom-up strategies that assemble spheroids or organoids as modular building blocks offer a more effective route to organ-like constructs. Nevertheless, they suffer from low reproducibility because of spontaneous cell self-assembly. Three-dimensional bioprinting provides a promising solution for the reproducible fabrication of multicellular organ building blocks (OBBs). At the same time, while extrusion-based bioprinting offers high reproducibility, its limited dimensional accuracy has restricted its use for fabricating OBBs that require both precise microarchitectures and reliable assembly. Here, we address this limitation by introducing a strategy in which bioinks are directly bioprinted within three-dimensionally printed molds, enabling the formation of OBBs with well-defined geometries and controlled spatial organization. By combining mold-guided bioprinting with multimaterial preset extrusion, we demonstrated the fabrication of heterogeneous OBBs with microscale architectures while preserving the modularity essential for bottom-up assembly. This approach resolves the conventional trade-off between structural precision and assembly-based scalability, allowing the construction of large tissue constructs with hierarchical vascular networks. Overall, this work presents a 3D bioprinting-based OBB fabrication strategy that integrates precision manufacturing with bottom-up tissue assembly, offering a reproducible and scalable framework for bioartificial organ engineering.

Indexed as

3D bioprintingBioartificial organHierarchical vascularized tissueOrgan building block (OBB)Preset extrusion bioprinting

Identifiers

PMID41631208
PMCPMC12860649

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.